SCHEMBL7684049

SCHEMBL7684049

COc1ccc(Cn2cc3c(n2)CC(F)CC(Br)C3=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AADAT Q8N5Z0 3/20 0.47
CMA1 P23946 1/20 0.37
PTGS2 P35354 1/20 0.36
GSK3A P49840 2/20 0.36
GSK3B P49841 2/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
PARK7 Q99497 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
PDE5A O76074 1/20 0.35
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
HDAC1 Q13547 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL365650 0.88 AADAT (0.46) AADATCMA1GSK3AGSK3BMEN1
SCHEMBL15182502 0.82 AADAT (0.43) AADATCMA1PTGS2GSK3AGSK3B
SCHEMBL365849 0.82 AADAT (0.44) AADATCMA1GSK3AGSK3BMEN1
SCHEMBL365671 0.81 AADAT (0.43) AADATMEN1KMT2ANPC1RAB9A
SCHEMBL365853 0.81 AADAT (0.45) AADATCMA1GSK3AGSK3BMEN1
SCHEMBL6837143 0.81 AADAT (0.45) AADATCMA1GSK3AGSK3BMEN1
SCHEMBL7670133 0.81 AADAT (0.47) AADATCMA1PTGS2GSK3AGSK3B
SCHEMBL366319 0.76 AADAT (0.47) AADATCMA1GSK3AGSK3BMEN1
SCHEMBL29191592 0.76 AADAT (0.51) AADATCMA1GSK3AGSK3BMEN1
SCHEMBL29191609 0.76 AADAT (0.51) AADATCMA1GSK3AGSK3BMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130210807-A1 Tricyclic Compounds as Allosteric Modulators of Metabotropic Glutamate Receptors. MERCK SHARP & DOHME CORP. 2013-08-15 US disclosed
WO-2012006760-A1 TRICYCLIC COMPOUNDS AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS MERCK SHARP & DOHME CORP. (US) 2012-01-19 WO disclosed
WO-2012008999-A2 TRICYCLIC COMPOUNDS AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS MERCK SHARP & DOHME CORP. (US) 2012-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130210807-A1 Tricyclic Compounds as Allosteric Modulators of Metabotropic Glutamate Receptors. GRM3, GRM6, GRM1 AADAT 3254/4885CMA1 4804/4885PTGS2 3106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.